Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Works matching AU Bleuse, Jean-Pierre
Results: 7
1
2
Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial.
- Published in:
- Oncologist, 2011, v. 16, n. 11, p. 1557, doi. 10.1634/theoncologist.2011-0141
- By:
- Publication type:
- Article
3
Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the "APAD1" randomized controlled trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 2, p. 709, doi. 10.1007/s10549-012-2084-7
- By:
- Publication type:
- Article
5
High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 94, n. 3, p. 255, doi. 10.1007/s10549-005-9008-8
- By:
- Publication type:
- Article
6
Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial.
- Published in:
- Nutrients, 2020, v. 12, n. 10, p. 3081, doi. 10.3390/nu12103081
- By:
- Publication type:
- Article
7
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article